Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
194 Leser
Artikel bewerten:
(0)

Nebulizer Market, 2022 - Research and Markets

DUBLIN, Apr. 25, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Nebulizer Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 to 2022" report to their offering.

Research and Markets Logo

The Global Nebulizer market was valued at USD 752.8 Mn in 2015, and is expected to reach USD 1,162.2 Mn by 2022, expanding at a CAGR of 6.4% from 2016 to 2022.

The market is segments by three types of nebulizers, pneumatic nebulizers, ultrasonic nebulizers, and mesh nebulizers. In 2015, pneumatic nebulizers dominated the market and accounted for the market share of 63.8%. The key factors assisting the growth of this segment are high patient compliance, efficient drug delivery, and cost efficient compared to other types of nebulizers.

As of the current market scenario, North America is the largest regional market for Nebulizer technology. The highest market share of the region is attributed to growing prevalence and diagnosis rate of COPD and respiratory disease, with increasing awareness and acceptance to novel technology and reimbursement. Asia Pacific is lucrative and the fastest progressing market during the forecast period. Some prime factors attributed to the progress of Asia Pacific markets include emerging economies increase investment of healthcare infrastructure, surge in prevalence of respiratory diseases due to pollution and smoking

Key Market Movements:

  • Rising prevalence of respiratory diseases due to environmental, habitual, and congenital reasons
  • Rising patient awareness associated with the use of nebulizers
  • Rising disposable income and patient awareness, coupled with introduction of cost effective and portable nebulizers have led to the market penetration in Asia Pacific

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Global Nebulizers Market Overview

Chapter 4 Nebulizer Market, By Devices

Chapter 5 Global Nebulizers Analysis, by End-User

Chapter 6 Global Nebulizers Market, By Geography

Chapter 7 Company Profiles

  • Allied Healthcare Products, Inc.
  • Becton Dickinson and Company (CareFusion)
  • Medtronic PLC
  • DeVillbiss Healthcare LLC
  • Aerogen
  • PARI GmbH
  • Koninklijke Philips N.V.
  • Omron Healthcare, Co., Ltd.
  • GF Health Products, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/b4jxfj/global_nebulizer

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.